Table of Contents

• Rhonda M. Clifford,
• Wendy A. Davis,
• Kevin T. Batty,
• and Timothy M.E. Davis

Effect of a Pharmaceutical Care Program on Vascular Risk Factors in Type 2 Diabetes: The Fremantle Diabetes Study

• Johan Wadén,
• Heikki Tikkanen,
• Carol Forsblom,
• Johan Fagerudd,
• Kim Pettersson-Fernholm,
• Timo Lakka,
• Mikael Riska,
• and Per-Henrik Groop

Leisure Time Physical Activity Is Associated With Poor Glycemic Control in Type 1 Diabetic Women: The FinnDiane study

• Jeffrey A. Johnson,
• Dean T. Eurich,
• Ellen L. Toth,
• Richard Z. Lewanczuk,
• TK Lee,
• and Sumit R. Majumdar

Generalizability and Persistence of a Multifaceted Intervention for Improving Quality of Care for Rural Patients With Type 2 Diabetes

• Laurence Kennedy and
• William H. Herman

Renal Status Among Patients Using Metformin in a Primary Care Setting

• Hajime Yamagata,
• Yutaka Kiyohara,
• Shotaro Nakamura,
• Michiaki Kubo,
• Yumihiro Tanizaki,
• Takayuki Matsumoto,
• Keiichi Tanaka,
• Isao Kato,
• Tomoko Shirota,
• and Mitsuo Iida

Impact of Fasting Plasma Glucose Levels on Gastric Cancer Incidence in a General Japanese Population: The Hisayama Study

• Levent Özdemir,
• Saniye Topçu,
• Işılay Nadir,
• Naim Nur,
• Seher Arslan,
• and Haldun Sümer

The Prevalence of Diabetes and Impaired Glucose Tolerance in Sivas, Central Anatolia, Turkey

• Gang Hu,
• Pekka Jousilahti,
• Noël C. Barengo,
• Qing Qiao,
• Timo A. Lakka,
• and Jaakko Tuomilehto

Physical Activity, Cardiovascular Risk Factors, and Mortality Among Finnish Adults With Diabetes

• Alessandra Doolan,
• Kim Donaghue,
• Jan Fairchild,
• Melanie Wong,
• and Andrew J. Williams

Use of HLA Typing in Diagnosing Celiac Disease in Patients With Type 1 Diabetes

• Finlay A. McAlister,
• Sumit R. Majumdar,
• Sandra Blitz,
• Brian H. Rowe,
• Jacques Romney,
• and Thomas J. Marrie

The Relation Between Hyperglycemia and Outcomes in 2,471 Patients Admitted to the Hospital With Community-Acquired Pneumonia

• Michele Heisler,
• John D. Piette,
• Michael Spencer,
• Edie Kieffer,
• and Sandeep Vijan

The Relationship Between Knowledge of Recent HbA_1c Values and Diabetes Care Understanding and Self-Management

• Ronny A. Bell,
• Shannon L. Smith,
• Thomas A. Arcury,
• Beverly M. Snively,
• Jeanette M. Stafford,
• and Sara A. Quandt

Prevalence and Correlates of Depressive Symptoms Among Rural Older African Americans, Native Americans, and Whites With Diabetes

Depression Symptoms and Antidepressant Medicine Use in Diabetes Prevention Program Participants

• Sloane J. Freeman,
• Wendy Roberts,
• and Denis Daneman

Type 1 Diabetes and Autism: Is there a link?

• Vincent Rigalleau,
• Catherine Lasseur,
• Caroline Perlemoine,
• Nicole Barthe,
• C. Raffaitin,
• Chung Liu,
• Phillipe Chauveau,
• Laurence Baillet-Blanco,
• Marie-Christine Beauvieux,
• C. Combe,
• and Henri Gin

Estimation of Glomerular Filtration Rate in Diabetic Subjects: Cockcroft formula or Modification of Diet in Renal Disease study equation?

• Jeroen P.H. van Wijk,
• Eelco J.P. de Koning,
• Manuel Castro Cabezas,
• and Ton J. Rabelink

Rosiglitazone Improves Postprandial Triglyceride and Free Fatty Acid Metabolism in Type 2 Diabetes

• Jennifer M. Barker,
• Jeesuk Yu,
• Liping Yu,
• Jian Wang,
• Dongmei Miao,
• Fei Bao,
• Edward Hoffenberg,
• Jerald C. Nelson,
• Peter A. Gottlieb,
• Marian Rewers,
• and George S. Eisenbarth

Autoantibody “Subspecificity” in Type 1 Diabetes: Risk for organ-specific autoimmunity clusters in distinct groups

• Patrícia El Beitune,
• Geraldo Duarte,
• Milton C. Foss,
• Renan M. Montenegro, Jr,
• Silvana M. Quintana,
• Ernesto A. Figueiró-Filho,
• and Antonio A. Nogueira

Effect of Maternal Use of Antiretroviral Agents on Serum Insulin Levels of the Newborn Infant

• Marjan Alssema,
• Jacqueline M. Dekker,
• Giel Nijpels,
• Coen D.A. Stehouwer,
• Lex M. Bouter,
• and Robert J. Heine

Proinsulin Concentration Is an Independent Predictor of All-Cause and Cardiovascular Mortality: An 11-year follow-up of the Hoorn Study

• Peter A. Senior,
• Robert C. Welsh,
• Charlotte G. McDonald,
• Breay W. Paty,
• A.M. James Shapiro,
• and Edmond A. Ryan

Coronary Artery Disease Is Common in Nonuremic, Asymptomatic Type 1 Diabetic Islet Transplant Candidates

• Cristina Hernández,
• Gemma Francisco,
• Pilar Chacón,
• and Rafael Simó

Lipoprotein(a) as a Risk Factor for Cardiovascular Mortality in Type 2 Diabetic Patients: A 10-year follow-up study

• Per M. Humpert,
• Renate Neuwirth,
• Marco J. Battista,
• Olga Voronko,
• Maximilian von Eynatten,
• Ilze Konrade,
• Gottfried Rudofsky, Jr,
• Thoralf Wendt,
• Andreas Hamann,
• Michael Morcos,
• Peter P. Nawroth,
• and Angelika Bierhaus

SDF-1 Genotype Influences Insulin-Dependent Mobilization of Adult Progenitor Cells in Type 2 Diabetes

• James E. Sharman,
• Zhi Y. Fang,
• Brian Haluska,
• Michael Stowasser,
• Johannes B. Prins,
• and Thomas H. Marwick

Left Ventricular Mass in Patients With Type 2 Diabetes Is Independently Associated With Central but not Peripheral Pulse Pressure

• Matilde Masini,
• Daniela Campani,
• Ugo Boggi,
• Michele Menicagli,
• Nicola Funel,
• Maria Pollera,
• Roberto Lupi,
• Silvia Del Guerra,
• Marco Bugliani,
• Scilla Torri,
• Stefano Del Prato,
• Franco Mosca,
• Franco Filipponi,
• and Piero Marchetti

Hepatitis C Virus Infection and Human Pancreatic β-Cell Dysfunction

• Jamal S. Rana,
• Pascalle S. Monraats,
• Aeilko H. Zwinderman,
• Moniek P.M. de Maat,
• John J.P. Kastelein,
• Pieter A.F. Doevendans,
• Robbert J. de Winter,
• René A. Tio,
• Rune R. Frants,
• Arnoud van der Laarse,
• Ernst E. van der Wall,
• and J. Wouter Jukema

Metabolic Syndrome and Risk of Restenosis in Patients Undergoing Percutaneous Coronary Intervention

• Earl S. Ford,
• Umed A. Ajani,
• and Ali H. Mokdad

The Metabolic Syndrome and Concentrations of C-Reactive Protein Among U.S. Youth

• Angelo Scuteri,
• Samer S. Najjar,
• Christopher H. Morrell,
• and Edward G. Lakatta

The Metabolic Syndrome in Older Individuals: Prevalence and Prediction of Cardiovascular Events: The Cardiovascular Health Study

Impact of Intensive Lifestyle and Metformin Therapy on Cardiovascular Disease Risk Factors in the Diabetes Prevention Program

• SoJung Lee,
• Jennifer L. Kuk,
• Peter T. Katzmarzyk,
• Steven N. Blair,
• Timothy S. Church,
• and Robert Ross

Cardiorespiratory Fitness Attenuates Metabolic Risk Independent of Abdominal Subcutaneous and Visceral Fat in Men

• Ram Weiss,
• Sara E. Taksali,
• William V. Tamborlane,
• Tania S. Burgert,
• Mary Savoye,
• and Sonia Caprio

Predictors of Changes in Glucose Tolerance Status in Obese Youth

• Salvatore De Cosmo,
• Antonio Minenna,
• Oznelle Ludovico,
• Sandra Mastroianno,
• Anna Di Giorgio,
• Leonardo Pirro,
• and Vincenzo Trischitta

Increased Urinary Albumin Excretion, Insulin Resistance, and Related Cardiovascular Risk Factors in Patients With Type 2 Diabetes: Evidence of a sex-specific association

• Amy E. Baughcum,
• Suzanne Bennett Johnson,
• Stacy K. Carmichael,
• Adam B. Lewin,
• Jin-Xiong She,
• and Desmond A. Schatz

Maternal Efforts to Prevent Type 1 Diabetes in At-Risk Children

• Gholam Reza Pishdad

Low Incidence of Type 1 Diabetes in Iran

• Marc Petre,
• Paul Tokar,
• Debra Kostar,
• and Peter R. Cavanagh

Revisiting the Total Contact Cast: Maximizing off-loading by wound isolation

• Roberto Vettor,
• Roberto Serra,
• Roberto Fabris,
• Claudio Pagano,
• and Giovanni Federspil

Effect of Sibutramine on Weight Management and Metabolic Control in Type 2 Diabetes: A meta-analysis of clinical studies

• Julio Rosenstock,
• George Dailey,
• Massimo Massi-Benedetti,
• Andreas Fritsche,
• Zhengning Lin,
• and Alan Salzman

Reduced Hypoglycemia Risk With Insulin Glargine: A meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes

• Andrew J.M. Boulton,
• Arthur I. Vinik,
• Joseph C. Arezzo,
• Vera Bril,
• Eva L. Feldman,
• Roy Freeman,
• Rayaz A. Malik,
• Raelene E. Maser,
• Jay M. Sosenko,
• and Dan Ziegler

Diabetic Neuropathies: A statement by the American Diabetes Association

• Zachary T. Bloomgarden

Diabetic Retinopathy and Neuropathy

• Samuel Dagogo-Jack

Primary Prevention of Cardiovascular Disease in Pre-Diabetes: The glass is half full and half empty

• Michael Bryer-Ash and
• Alan J. Garber

Point: Inpatient Glucose Management: The emperor finally has clothes

• Silvio E. Inzucchi and
• Julio Rosenstock

Counterpoint: Inpatient Glucose Management: A premature call to arms?

• Betül Ersoy,
• Afig Hüseyinov,
• and Şükran Darcan

The Role of Platelet-Activating Factor in Pathogenesis of Type 1 Diabetes

• Javier Reyes-Balaguer,
• Elena Solaz-Moreno,
• Carmen Morata-Aldea,
• and Patricia Elorza-Montesinos

Spontaneous Diabetic Myonecrosis

• Bryan J. Krajicek,
• Yogish C. Kudva,
• and Heather A. Hurley

Potentially Important Contribution of Dextrose Used as Diluent to Hyperglycemia in Hospitalized Patients

• Graziano Di Cianni,
• Laura Volpe,
• Cristina Lencioni,
• Kyriazoula Chatzianagnostou,
• Ilaria Cuccuru,
• Alessandra Ghio,
• Luca Benzi,
• and Stefano Del Prato

Use of Insulin Glargine During the First Weeks of Pregnancy in Five Type 1 Diabetic Women

• Cengiz Kara,
• Alev Oguz Kutlu,
• Olcay Evliyaoglu,
• Hatice Bilgili,
• and Nurdan Yildirim

Successful Treatment of Insulin Allergy in a 1-Year-Old Infant With Neonatal Diabetes by Lispro and Glargine Insulin

• A. Paul Lambert and
• Colin F. Close

Charcot Neuroarthropathy of the Wrist in Type 1 Diabetes

• Roy Eldor and
• Itamar Raz

Lipids and Glucose in Type 2 Diabetes: What About the β-Cell and the Mitochondria?: Response to Boden and Laakso

• Guenther Boden and
• Markku Laakso

Lipids and Glucose in Type 2 Diabetes: What About the β-Cell and the Mitochondria?: Response to Eldor and Raz

Errata